scPharmaceuticals Inc. (SCPH): Price and Financial Metrics


scPharmaceuticals Inc. (SCPH)

Today's Latest Price: $8.35 USD

0.34 (-3.91%)

Updated Jun 5 2:55pm

Add SCPH to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SCPH Daily Price Range
SCPH 52-Week Price Range

SCPH Stock Price Chart More Charts


SCPH Price/Volume Stats

Current price $8.35 52-week high $11.99
Prev. close $8.69 52-week low $2.78
Day low $8.27 Volume 105,751
Day high $8.74 Avg. volume 89,926
50-day MA $9.11 Dividend yield N/A
200-day MA $6.92 Market Cap 175.43M

scPharmaceuticals Inc. (SCPH) Company Bio


scPharmaceuticals Inc. engages in the development and commercialization of transformative pharmaceutical products. The company’s under development products are for heart failure and infectious diseases that include Furoscix that is for treatment of worsening or decompensated heart failure outside of the inpatient setting. scPharmaceuticals Inc. formerly known as scPharmaceuticals LLC. and changed its name to scPharmaceuticals Inc. in March 2014. The company was founded 2013 and is based in Burlington, Massachusetts.


SCPH Latest News Stream


Event/TimeNews Detail
Loading, please wait...

SCPH Latest Social Stream


Loading social stream, please wait...

View Full SCPH Social Stream

Latest SCPH News From Around the Web

Below are the latest news stories about scPharmaceuticals Inc that investors may wish to consider to help them evaluate SCPH as an investment opportunity.

scPharmaceuticals Inc. to Present at Upcoming Investor Conferences

scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive officer, will present at the following investor conferences in June:

Yahoo | May 28, 2020

Why scPharmaceuticals Stock Plunged Today

What happened Shares of scPharmaceuticals (NASDAQ: SCPH) have plunged today, down by 22% as of 1 p.m. EDT, after the company announced the pricing of a public secondary offering. The deal priced at $8.

Yahoo | May 21, 2020

scPharmaceuticals Announces Pricing of Public Offering of Common Stock

scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced the pricing of an underwritten public offering of 5,780,347 shares of its common stock at a public offering price of $8.65 per share, before deducting underwriting discounts and commissions and other offering expenses, for gross proceeds of approximately $50.0 million. All shares of common stock to be sold in the offering are being offered by scPharmaceuticals. The Company has also granted the underwriters a 30-day option to purchase from the Company up to an additional 867,052 shares of common stock at the public offering price, less und...

Yahoo | May 21, 2020

scPharmaceuticals Inc. Announces Proposed Underwritten Public Offering of Common Stock

scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it has commenced an underwritten public offering of shares of its common stock. All shares of common stock to be sold in the offering will be offered by scPharmaceuticals. In addition, the underwriters will have a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public offering price less the underwriting discount. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the a...

Yahoo | May 20, 2020

scPharmaceuticals Inc. Reports First Quarter 2020 Financial Results and Provides Business Update

BURLINGTON, Mass.--(BUSINESS WIRE)---- $SCPH #FUROSCIX--scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced financial results for the first quarter ended March 31, 2020 and provided a business update. Business Update Remain on track to resubmit the FUROSCIX New Drug Application (NDA) under the current 505(b)(2) appro

Business Wire | May 12, 2020

Read More 'SCPH' Stories Here

SCPH Price Returns

1-mo -18.85%
3-mo -11.36%
6-mo 93.74%
1-year 148.51%
3-year N/A
5-year N/A
YTD 47.53%
2019 50.53%
2018 -68.90%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7204 seconds.